glp-1 and sibo medications can be powerful tools for blood sugar weight loss but they also slow gut motility more than most people realize. GLP-1 naturally delays stomach emptying and intestinal movement. When The Interplay Between GLP-1-Based Therapies,

Of note, a loading or induction phase is not strictly necessary

In patients in whom the major therapeutic goal is the compelling need to minimize the therapeutic risk pf hypoglycaemia, DPP-4 inhibitors are recommended as second line therapy after metformin failure at the same level as second line treatment options with GLP-1 receptor agonists, SGLT-2 inhibitors, or TZDs

A: Once your weight has stabilized and your GLP-1 routine is consistent

Which is better, Wegovy or Mounjaro

Studies suggest that both the sympathetic and parasympathetic components of the autonomic nervous system are affected in DGp since abnormalities have been described in the axons and dendrites within the prevertebral sympathetic ganglia